1. Home
  2. TCBK vs KRSA Comparison

TCBK vs KRSA Comparison

Compare TCBK & KRSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$52.78

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Korsana Biosciences Inc. Common Stock

KRSA

Korsana Biosciences Inc. Common Stock

N/A

Current Price

$30.25

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBK
KRSA
Founded
1975
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
TCBK
KRSA
Price
$52.78
$30.25
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
★ $57.84
$44.00
AVG Volume (30 Days)
★ 223.8K
125.5K
Earning Date
10-22-2026
11-11-2026
Dividend Yield
★ 2.73%
N/A
EPS Growth
6.94
★ 8.26
EPS
★ 2.10
N/A
Revenue
★ $53,445,000.00
$2,074,000.00
Revenue This Year
$7.81
N/A
Revenue Next Year
$4.06
N/A
P/E Ratio
$25.10
★ N/A
Revenue Growth
★ 4.12
3.70
52 Week Low
$43.22
$29.03
52 Week High
$61.71
$37.27

Technical Indicators

Market Signals
Indicator
TCBK
KRSA
Relative Strength Index (RSI) 51.91 43.55
Support Level $52.34 $29.98
Resistance Level $53.05 $35.78
Average True Range (ATR) 0.98 2.58
MACD 0.21 -0.14
Stochastic Oscillator 60.38 19.01

Price Performance

Historical Comparison
TCBK
KRSA

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income. Its banking and financial services are provided through full-service branches and commercial banking offices across California.

About KRSA Korsana Biosciences Inc. Common Stock

Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.

Share on Social Networks: